| Revision as of 00:28, 4 February 2005 editAndrewWatt (talk | contribs)690 editsNo edit summary← Previous edit | Revision as of 10:03, 24 February 2005 edit undoXezbeth (talk | contribs)Autopatrolled, Administrators282,561 editsmNo edit summaryNext edit → | ||
| Line 4: | Line 4: | ||
| Furthermore, duloxentine lacks affinity for ] ] within the ]. While there is limited data available regarding the ] profile of duloxetine in humans, its ] is reported to be 10 to 15 hours. | Furthermore, duloxentine lacks affinity for ] ] within the ]. While there is limited data available regarding the ] profile of duloxetine in humans, its ] is reported to be 10 to 15 hours. | ||
| ==External |
==External links== | ||
| * | * | ||
Revision as of 10:03, 24 February 2005
Duloxetine hydrochloride (brand name: Cymbalta) is a medically used drug that primarily targets major depressive disorders (MDD) and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(S)-N-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors.
Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. While there is limited data available regarding the pharmacokinetic profile of duloxetine in humans, its half-life is reported to be 10 to 15 hours.
External links
 | This medical article is a stub. You can help Misplaced Pages by expanding it. |
 | This chemistry-related article is a stub. You can help Misplaced Pages by expanding it. |